September 18, 2019
The study evaluated patients with type 1 diabetes and was presented at the Meeting of the European Association for the...
September 12, 2019
A report from Reports and Data suggests the overall Alzheimer's market will be worth US$12.43 billion by 2026.
January 13, 2019
Axsome Therapeutics, Checkpoint Therapeutics, Bellerophon Therapeutics, Enochian Bioscience and Equillium were last week's top gainers.
October 21, 2018
MannKind, Sierra Oncology, Eiger BioPharmaceuticals, Aevi Genomic Medicine and KalVista Pharmaceuticals were last week's top gainers on the NASDAQ Biotechnology...
October 7, 2018
vTv Therapeutics, Trevena, Cyclacel Pharmaceuticals, Paratek Pharmaceuticals and Avadel Pharmaceuticals were last week's top gainers on the NASDAQ Biotechnology Index.
June 13, 2018
vTv Therapeutics (Nasdaq:VTVT) today announced that results from Part B of the Company’s STEADFAST Study of the investigational medication azeliragon in...